NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK, Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ, Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO a Raul G NOGUEIRA. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. JOURNAL OF STROKE. SEOUL: KOREAN STROKE SOC, 2022, roč. 24, č. 2, s. 256-265. ISSN 2287-6391. Dostupné z: https://dx.doi.org/10.5853/jos.2022.00752.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
Autoři NGUYEN, Thanh N (garant), Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK (203 Česká republika, domácí), Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ (203 Česká republika), Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO a Raul G NOGUEIRA.
Vydání JOURNAL OF STROKE, SEOUL, KOREAN STROKE SOC, 2022, 2287-6391.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30230 Other clinical medicine subjects
Stát vydavatele Korejská republika
Utajení není předmětem státního či obchodního tajemství
WWW STROKE
Impakt faktor Impact factor: 8.200
Kód RIV RIV/00216224:14110/22:00127760
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.5853/jos.2022.00752
UT WoS 000812327500008
Klíčová slova česky COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke
Klíčová slova anglicky COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke
Štítky 14110127, Excelence Science, FNUSA, MU, RIV, rivok, Stroke, user, článek v časopise
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 5. 4. 2023 14:01.
Anotace
Since the first case in December 2019, coronavirus disease 2019 (COVID-19) has been responsible for more than 340 million infections and over 5.5 million deaths.1 Though most of the morbidity and mortality associated with COVID-19 is related to pulmonary complications, the disease has had wide-ranging systemic effects, including a range of neurological manifestations2,3 and disruption of coagulation homeostasis.4-7 This disruption in normal coagulation may trigger abnormal clotting events such as venous thromboembolism and stroke.8-10 Cerebral venous thrombosis (CVT) is a rare cause of stroke caused by the formation of clots in the brain’s venous system. The incidence of CVT has been reported to increase over the last decade, either from changing risk factors or improved detection.11-13 Compared to other forms of stroke, the incidence of CVT is more common in younger patients and women. CVT generally has a favorable prognosis with a good 90-day neurological outcome seen in greater than 80% of patients.
Návaznosti
90128, velká výzkumná infrastrukturaNázev: CZECRIN III
VytisknoutZobrazeno: 17. 7. 2024 19:20